Literature DB >> 10486249

Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.

M Nakanishi1, Y Kaneko, H Matsushime, K Ikeda.   

Abstract

The p21CKI forms a physical complex with the retinoblastoma protein (pRb) both in vitro and in vivo. The A/B pocket region of pRb and the N-terminal region of p21 were indispensable for this interaction. Among p21 family members, p57, but not p27, associated with pRb. Overexpression of cyclin D1, Cdk4, and E2F1 in the cells expressing pRb and p21 did not perturb the interaction between p21 and pRb. Coexpression of p21 in cells expressing pRb, cyclin D1, and Cdk4 prevented pRb hyperphosphorylation by cyclin D1/Cdk4. On the other hand, hyperphosphorylation of pRb by an excess amount of cyclin/Cdk disrupted pRb/p21 complex formation in vitro. These findings suggest that pRb may be dynamically regulated by the relative binding and activities of p21 and Cdks. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10486249     DOI: 10.1006/bbrc.1999.1296

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Posttranslational phosphorylation of mutant p53 protein in tumor development.

Authors:  Manabu Matsumoto; Mutsuo Furihata; Yuji Ohtsuki
Journal:  Med Mol Morphol       Date:  2006-06       Impact factor: 2.309

2.  p21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker.

Authors:  Magdalena B Flak; Claire M Connell; Claude Chelala; Kyra Archibald; Michael A Salako; Katrina J Pirlo; Michelle Lockley; Sally P Wheatley; Frances R Balkwill; Iain A McNeish
Journal:  Mol Cancer       Date:  2010-07-03       Impact factor: 27.401

3.  Common and specific roles of the related CDK inhibitors p27 and p57 revealed by a knock-in mouse model.

Authors:  Etsuo Susaki; Keiko Nakayama; Lili Yamasaki; Keiichi I Nakayama
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-10       Impact factor: 11.205

Review 4.  Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting.

Authors:  Liz J Hernández Borrero; Wafik S El-Deiry
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-04-29       Impact factor: 11.414

5.  Stable low-level expression of p21WAF1/CIP1 in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation control.

Authors:  Timothy G Graves; Michael W Harr; Erin L Crawford; James C Willey
Journal:  Mol Cancer       Date:  2006-01-10       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.